Shareholder Votes

Azitra, Inc. shareholders approved Election of four director nominees: Francisco D. Salva, Travis Whitfill, Barbara Ryan, and John Schroer. at the 2026-06-15 meeting.

“Proposal No. 1. Stockholders approved the election of the four director nominees named in the Proxy Statement to serve as members of the Board of Directors (the “Board”) of the Company until the next annual meeting of stockholders and until their successors are duly elected and qualified. The director nominees named in the Proxy Statement for election to the Company’s Board were the following individuals: Francisco D. Salva, Travis Whitfill, Barbara Ryan and John Schroer, with shares voted as follows: Name For Withheld Broker Non-Votes Francisco D. Salva 639,815 576,647 4,861,794 Travis Whitfill 642,109 574,353 4,861,794 Barbara Ryan 1,087,320 129,142 4,861,794 John Schroer 643,985 572,477 4,861,794”

GYRE THERAPEUTICS, INC. shareholders approved Approval of Conversion of Series B Preferred Stock at the 2026-06-10 meeting.

“Proposal 4: Approval of Conversion of Series B Preferred Stock The issuance of shares of the Company’s common stock, par value $0.001 per share, upon conversion of the Company’s Series B Convertible Preferred Stock, par value $0.001 per share, was approved, in accordance with Nasdaq Listing Rule 5635(a), as follows: Votes For Votes Against Abstentions Broker Non-Votes 70,497,125 16,031 1,285 1,985,197”

GYRE THERAPEUTICS, INC. shareholders approved Ratification of Independent Auditor at the 2026-06-10 meeting.

“Proposal 3: Ratification of Independent Auditor The appointment of Grant Thornton Zhitong Certified Public Accountants LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was ratified as follows: Votes For Votes Against Abstentions Broker Non-Votes 72,487,596 11,626 416 0”

GYRE THERAPEUTICS, INC. shareholders approved Non-Binding Advisory Vote on Executive Compensation at the 2026-06-10 meeting.

“Proposal 2: Non-Binding Advisory Vote on Executive Compensation The compensation of the Company’s named executive officers was approved, on a non-binding, advisory basis, as follows: Votes For Votes Against Abstentions Broker Non-Votes 70,478,374 34,907 1,160 1,985,197”

GYRE THERAPEUTICS, INC. shareholders approved Election of Class II Directors at the 2026-06-10 meeting.

“The following Class II director nominees were elected to serve until the 2029 Annual Meeting of Stockholders based upon the following votes: Nominee Votes For Votes Withheld Broker Non-Votes • David M. Epstein, Ph.D. 70,160,332 354,109 1,985,197 • Dan Weng, M.D. 70,483,425 31,016 1,985,197”

ENCORE CAPITAL GROUP INC shareholders voted on Non-binding vote to recommend the frequency of future non-binding stockholder votes to approve the compensation of the Company’s named executive officers. at the 2026-06-12 meeting.

“The sixth proposal was to recommend, in a non-binding vote, the frequency of future non-binding stockholder votes to approve the compensation of the Company’s named executive officers. In a non- binding vote, the Company’s stockholders recommended a non-binding vote to approve the compensation of the Company’s named executive officers every year, with the following votes tabulated: One Year Two Years Three Years Abstain Broker Non-Vote 17,429,161 12,878 908,853 9,259 1,020,746”

ENCORE CAPITAL GROUP INC shareholders approved Approve and adopt an amendment to the Company’s Amended and Restated Certificate of Incorporation to provide for exculpation of officers. at the 2026-06-12 meeting.

“The fifth proposal was to approve and adopt an amendment to the Company’s Amended and Restated Certificate of Incorporation to provide for exculpation of officers. The amendment to the Company’s Amended and Restated Certificate of Incorporation to provide for exculpation of officers was approved, with the following votes tabulated: For Against Abstain Broker Non-Vote 16,593,440 1,758,739 7,972 1,020,746”

ENCORE CAPITAL GROUP INC shareholders approved Approve the Amended and Restated Encore Capital Group, Inc. 2017 Incentive Award Plan. at the 2026-06-12 meeting.

“The fourth proposal was to approve the Amended and Restated Encore Capital Group, Inc. 2017 Incentive Award Plan. The Amended and Restated Encore Capital Group, Inc. 2017 Incentive Award Plan was approved, with the following votes tabulated: For Against Abstain Broker Non-Vote 17,191,591 1,159,793 8,767 1,020,746”

ENCORE CAPITAL GROUP INC shareholders approved Ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-12 meeting.

“The third proposal was the ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified, with the following votes tabulated: For Against Abstain Broker Non-Vote 18,999,367 369,506 12,024 —”

ENCORE CAPITAL GROUP INC shareholders approved Non-binding vote to approve the compensation of the Company’s named executive officers. at the 2026-06-12 meeting.

“The second proposal was a non-binding vote to approve the compensation of the Company’s named executive officers. In a non-binding vote, the compensation of the Company’s named executive officers was approved, with the following votes tabulated: For Against Abstain Broker Non-Vote 17,997,698 313,483 48,970 1,020,746”

ENCORE CAPITAL GROUP INC shareholders approved Election of eight directors: Michael P. Monaco, William C. Goings, Ashwini (Ash) Gupta, Jeffrey A. Hilzinger, Angela A. Knight, Laura Newman Olle, Richard P. Stovsky and Ashish Masih at the 2026-06-12 meeting.

“The first proposal was for the election of the following eight directors: Michael P. Monaco, William C. Goings, Ashwini (Ash) Gupta, Jeffrey A. Hilzinger, Angela A. Knight, Laura Newman Olle, Richard P. Stovsky and Ashish Masih. All eight directors were elected, with the following votes tabulated: For Withhold Broker Non-Votes Michael P. Monaco 18,044,582 315,569 1,020,746 William C. Goings 16,654,942 1,705,209 1,020,746 Ashwini (Ash) Gupta 18,153,822 206,329 1,020,746 Jeffrey A. Hilzinger 17,847,500 512,651 1,020,746 Angela A. Knight 18,002,444 357,707 1,020,746 Laura Newman Olle 18,013,725 346,426 1,020,746 Richard P. Stovsky 18,287,014 73,137 1,020,746 Ashish Masih 18,248,642 111,509 1,020,746”

KYNTRA BIO, INC. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2026-06-12 meeting.

“The stockholders ratified the selection of PricewaterhouseCoopers LLP, by the Audit Committee of the Kyntra Bio board of directors, as the independent registered public accounting firm of the Company for the year ending December 31, 2026: 2,712,825 shares of Common Stock voted for, 14,392 against, and 7,461 abstaining.”

KYNTRA BIO, INC. shareholders approved Advisory vote on executive compensation at the 2026-06-12 meeting.

“The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the 2026 definitive proxy statement filed on April 27, 2026: 1,242,005 shares of Common Stock voted for, 23,606 against, 24,639 abstaining, and 1,444,428 broker non-votes.”

KYNTRA BIO, INC. shareholders approved Election of Class III director nominee Michael Kauffman, M.D., Ph.D. at the 2026-06-12 meeting.

“The Class III director nominee, Michael Kauffman, M.D., Ph.D., was elected to hold office until the Company’s 2029 annual meeting of stockholders. The director received 96.04% of the shares voting: 1,239,169 shares of Common Stock voted for, 0 against, 51,081 withheld, and 1,444,428 broker non-votes.”

SANDRIDGE ENERGY INC shareholders approved Approval of the extension of the term of the Company's Omnibus Incentive Plan to 2036 at the 2026-06-10 meeting.

“Approval of the extension of the term of the Company’s Omnibus Incentive Plan to 2036.”

SANDRIDGE ENERGY INC shareholders approved Non-binding advisory vote to approve the compensation paid the Company's named executive officers during 2025 at the 2026-06-10 meeting.

“Non-binding advisory vote to approve the compensation paid the Company’s named executive officers during 2025; and (4) Approval of the extension of the term of the Company’s Omnibus Incentive Plan to 2036.”

SANDRIDGE ENERGY INC shareholders approved Ratification of the selection of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-10 meeting.

“Ratification of the selection of Grant Thornton LLP (“Grant Thornton”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026; (3) Non-binding advisory vote to approve the compensation paid the Company’s named executive officers during 2025; and (4) Approval of the extension of the term of the Company’s Omnibus Incentive Plan to 2036.”

SANDRIDGE ENERGY INC shareholders approved Election of six directors to serve on the Company's Board until the 2027 Annual Meeting of Stockholders at the 2026-06-10 meeting.

“Election of six directors to serve on the Company’s Board until the 2027 Annual Meeting of Stockholders; (2) Ratification of the selection of Grant Thornton LLP (“Grant Thornton”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026; (3) Non-binding advisory vote to approve the compensation paid the Company’s named executive officers during 2025; and (4) Approval of the extension of the term of the Company’s Omnibus Incentive Plan to 2036.”

UNITED STATES ANTIMONY CORP shareholders approved To ratify the appointment of Sadler, Gibb & Associates, LLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-12 meeting.

“3. To ratify the appointment of Sadler, Gibb & Associates, LLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 FOR AGAINST ABSTAIN BROKER NON-VOTES 68,138,061 462,650 21,152,698 -”

UNITED STATES ANTIMONY CORP shareholders approved To approve an amendment to the Certificate of Formation to increase the number of shares authorized for issuance by the Company at the 2026-06-12 meeting.

“2. To approve an amendment to the Certificate of Formation to increase the number of shares authorized for issuance by the Company FOR AGAINST ABSTAIN BROKER NON-VOTES 73,504,344 15,313,484 935,581 -”

UNITED STATES ANTIMONY CORP shareholders approved Election of seven directors named in the Proxy Statement for a term of one year at the 2026-06-12 meeting.

“At the 2026 Annual Shareholders Meeting of United States Antimony Corporation (the “Company” and “USAC”) held on June 12, 2026 (“Annual Meeting”), each of the proposals submitted to a vote of the shareholders received the requisite votes for approval. Set forth below are the final voting results from the Company’s Annual Meeting for each of the proposals submitted to a vote of the shareholders: 1. To elect each of the seven directors named in the Proxy Statement for a term of one year FOR AGAINST ABSTAIN BROKER NON-VOTES Gary C. Evans 43,201,379 - 5,914,028 40,638,002 Dr. Blaise Aguirre 26,190,118 - 22,925,289 40,638,002 Lloyd Joseph Bardswich 48,579,499 - 535,908 40,638,002 Joseph A. Carrabba 38,505,154 - 10,610,253 40,638,002 John M. Keane 47,603,382 - 1,512,025 40,638,002 Jon R. Marinelli 43,014,787 - 6,100,620 40,638,002 Michael A. McManus 38,515,214 - 10,600,193 40,638,002 2. To approve an amendment to the Certificate of Formation to increase the number of shares authorized for is”

BullFrog AI Holdings, Inc. shareholders approved Ratification of the appointment of M&K CPAs, PLLC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-11 meeting.

“Proposal No. 2 was the ratification of the appointment of M&K CPAs, PLLC (“M&K”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of the vote were as follows: Votes For Votes Against Abstentions 7,496,267 281,615 16,287 Based on the foregoing vote, the ratification of M&K as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved.”

BullFrog AI Holdings, Inc. shareholders approved Election of four nominees to serve as directors of the Company, each for a term of one year until the next annual meeting of the stockholders of the Company and until their successors have been duly elected and qualified. at the 2026-06-11 meeting.

“Proposal No. 1 was the election of four nominees to serve as directors of the Company, each for a term of one year until the next annual meeting of the stockholders of the Company and until their successors have been duly elected and qualified. The results of the vote were as follows: Nominee Votes For Votes Withheld Broker Non-Votes William Enright 2,632,748 63,149 5,098,272 Jason D. Hanson 2,633,747 62,150 5,098,272 R. Donald Elsey 2,629,527 66,370 5,098,272 Vininder Singh 2,616,590 79,307 5,098,272 Based on the foregoing votes, the four nominees listed above were elected to serve on the Board.”

Sweetgreen, Inc. shareholders approved Approval, on a non-binding, advisory basis, of the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. at the 2026-06-11 meeting.

“Proposal 3. The stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. The results of such vote were: FOR AGAINST ABSTAIN BROKER NON-VOTES 171,927,900 3,048,452 133,635 28,844,159”

Sweetgreen, Inc. shareholders approved Ratification of the selection by the Audit Committee of the Company’s Board of Directors of Deloitte & Touche LLP as the Company’s independent registered accounting firm for the fiscal year ending December 27, 2026. at the 2026-06-11 meeting.

“Proposal 2. The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 27, 2026. The results of such vote were: FOR AGAINST ABSTAIN BROKER NON-VOTES 203,336,007 533,524 84,615 0”

Sweetgreen, Inc. shareholders approved Election of nine directors to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified. at the 2026-06-11 meeting.

“Proposal 1. The stockholders elected each of the nine nominees named below to serve as directors until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified. The results of such vote were: FOR WITHHOLD BROKER NON-VOTES Neil Blumenthal 170,564,787 4,545,200 28,844,159 Julie Bornstein 168,409,910 6,700,077 28,844,159 Cliff Burrows 172,822,169 2,287,818 28,844,159 Nicolas Jammet 172,884,692 2,225,295 28,844,159 Montgomery Moran 169,478,402 5,631,585 28,844,159 Jonathan Neman 172,645,022 2,464,965 28,844,159 Dawn Ostroff 166,290,831 8,819,156 28,844,159 Nathaniel Ru 172,935,640 2,174,347 28,844,159 Bradley Singer 172,811,880 2,298,107 28,844,159”

SANUWAVE Health, Inc. shareholders approved Advisory, non-binding vote on the compensation paid to the Company’s named executive officers. at the 2026-06-11 meeting.

“Proposal 3. To approve, in an advisory, non-binding vote, the compensation paid to the Company’s named executive officers. Votes For Votes Against Abstain Broker Non-Votes 4,666,444 385,238 6,644 1,061,530”

SANUWAVE Health, Inc. shareholders approved Ratify the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-11 meeting.

“Proposal 2. To ratify the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Abstain Broker Non-Votes 6,057,957 45,261 16,638 –”

SANUWAVE Health, Inc. shareholders approved Election of five directors: Morgan Frank, Gregory Bazar, Jeffrey Blizard, Ian Miller and James Tyler to serve until the 2027 annual meeting. at the 2026-06-11 meeting.

“Proposal 1. To elect five directors, Morgan Frank, Gregory Bazar, Jeffrey Blizard, Ian Miller and James Tyler, to serve until the 2027 annual meeting of stockholders. Name Votes For Withheld Broker Non-Votes Morgan Frank 4,988,463 69,863 1,061,530 Gregory Bazar 4,706,567 351,759 1,061,530 Jeffrey Blizard 4,634,031 424,295 1,061,530 Ian Miller 4,244,965 813,361 1,061,530 James Tyler 4,292,161 766,165 1,061,530”

TechTarget, Inc. shareholders approved Advisory (non-binding) resolution to approve compensation of named executive officers at the 2026-06-11 meeting.

“Proposal No. 3 - The Company's stockholders approved, on an advisory (non-binding) basis, the resolution to approve the compensation of our named executive officers as described in the Proxy Statement, as set forth below: For Against Abstain Broker Non-Votes 59,205,814 1,783,709 297,153 6,706,849”

TechTarget, Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“Proposal No. 2 - The Company's stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, as set forth below: For Against Abstain Broker Non-Votes 66,852,804 197,687 943,034 0”

TechTarget, Inc. shareholders approved Election of directors for a term expiring at the 2027 annual meeting at the 2026-06-11 meeting.

“Proposal No. 1 - The Company's stockholders elected all of the director nominees named below and in the Proxy Statement to the Company’s Board of Directors for a term expiring at the Company’s 2027 annual meeting of stockholders and until such director's successor is duly elected and qualified or until such director's earlier death, resignation or removal, as set forth below: Director Nominee For Against Abstain Broker Non-Votes Sally Ashford 50,102,369 11,077,710 106,597 6,706,849 Stephen A. Carter 50,434,804 10,851,418 454 6,706,849 David Flaschen 57,145,104 4,140,412 1,160 6,706,849 M. Sean Griffey 54,720,326 6,565,190 1,160 6,706,849 Don Hawk 54,911,970 6,374,237 469 6,706,849 Patrick Martell 53,409,693 7,770,371 106,612 6,706,849 Gary Nugent 54,868,880 6,417,345 451 6,706,849 Perfecto Sanchez 54,939,002 6,344,804 2,870 6,706,849 Christina Van Houten 54,866,374 6,416,779 3,523 6,706,849”

HELIOS TECHNOLOGIES, INC. shareholders approved Approval of the Amendment and Restatement of the Helios Technologies, Inc. 2023 Equity Incentive Plan.

“Proposal 4. Approval of the Amendment and Restatement of the Helios Technologies, Inc. 2023 Equity Incentive Plan The proposal to approve the amendment and restatement of the Helios Technologies, Inc. 2023 Equity Incentive Plan, received the following votes: For 26,814,607 Against 713,697 Abstain 241,734 Broker Non-Votes 1,692,565”

HELIOS TECHNOLOGIES, INC. shareholders approved Advisory Vote to Approve Named Executive Officer Compensation.

“Proposal 3. Advisory Vote to Approve Named Executive Officer Compensation The proposal to approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s 2026 Proxy Statement, received the following votes: For 27,181,272 Against 345,922 Abstain 242,844 Broker Non-Votes 1,692,565”

HELIOS TECHNOLOGIES, INC. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm.

“Proposal 2. Ratification of the Appointment of Independent Registered Public Accounting Firm The proposal to ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm”

HELIOS TECHNOLOGIES, INC. shareholders approved Election of Directors Laura Dempsey Brown, Cariappa Chenanda, Alexander Schuetz, and Ian Walsh.

“The votes cast for and withheld were as follows: Director For Against Abstain Broker Non-Votes Laura Dempsey Brown 26,201,933 1,547,698 20,407 1,692,565 Cariappa Chenanda 26,433,807 1,315,789 20,442 1,692,565 Alexander Schuetz 26,372,584 1,377,098 20,356 1,692,565 Ian Walsh 26,661,742 1,086,395 21,901 1,692,565”

Gemini Space Station, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-15 meeting.

“Votes For Votes Against Abstain/Withheld Broker Non-Votes 769,400,614 1,387,756 617,368 —”

Gemini Space Station, Inc. shareholders approved Election of six directors: Tyler Winklevoss, Cameron Winklevoss, Jonathan Durham, James Anthony Esposito, Maria Filipakis, and Sachin Chand Jaitly at the 2026-06-15 meeting.

“Nominee Votes For Votes Withheld Broker Non-Votes Tyler Winklevoss 753,956,463 2,626,302 14,822,973 Cameron Winklevoss 753,851,546 2,731,219 14,822,973 Jonathan Durham 755,617,150 965,615 14,822,973 James Anthony Esposito 755,617,257 965,508 14,822,973 Maria Filipakis 755,593,413 989,352 14,822,973 Sachin Chand Jaitly 755,595,456 987,309 14,822,973”

TerrAscend Corp. shareholders approved Approval of all unallocated share units issuable under the Company's share unit plan. at the 2026-06-09 meeting.

“Proposal 4: Approval of Share Unit Plan Resolution The Company’s shareholders approved a resolution to approve all unallocated share units issuable under the Company's share unit plan, as described in more detail in the Circular. The final voting results are as follows: Votes For Votes Against Broker Non-Votes 145,756,998 1,435,234 48,597,797”

TerrAscend Corp. shareholders approved Approval of all unallocated stock options issuable under the Company's stock option plan. at the 2026-06-09 meeting.

“Proposal 3: Approval of Stock Option Plan Resolution The Company’s shareholders approved a resolution to approve all unallocated stock options issuable under the Company's stock option plan, as described in more detail in the Circular. The final voting results are as follows: Votes For Votes Against Broker Non-Votes 145,741,365 1,450,867 48,597,797”

TerrAscend Corp. shareholders approved Ratification of the re-appointment of MNP LLP as auditor. at the 2026-06-09 meeting.

“Proposal 2: Ratification of the Re-Appointment of Auditor The Company’s shareholders ratified the re-appointment of MNP LLP, Chartered Professional Accountants, of Toronto, Ontario, as the Company’s auditor and independent registered public accounting firm for the fiscal year ending December 31, 2026 and authorized the Board to fix their remuneration. The final voting results are as follows: Votes For Votes Withheld Broker Non-Votes 195,355,441 434,588 0”

TerrAscend Corp. shareholders approved Election of five directors: Craig Collard, Kara DioGuardi, Ira Duarte, Ed Schutter, and Jason Wild. at the 2026-06-09 meeting.

“Proposal 1: Election of Directors Each of the five individuals listed below was elected at the Annual Meeting to serve on the Company’s Board of Directors (the “Board”) until the close of the next annual meeting of shareholders of the Company following his or her election, or any postponement(s) or adjournment(s) thereof, unless his or her office is vacated earlier or until his or her successor is elected or appointed. The final voting results are as follows: Director Nominee Votes For Votes Withheld Broker Non-Votes Craig Collard 146,813,537 378,695 48,597,797 Kara DioGuardi 142,410,423 4,781,809 48,597,797 Ira Duarte 146,740,278 451,954 48,597,797 Ed Schutter 146,789,873 402,359 48,597,797 Jason Wild 146,763,699 428,533 48,597,797”

Hims & Hers Health, Inc. shareholders approved Advisory approval of the Company’s executive compensation at the 2026-06-11 meeting.

“Proposal 3 : Advisory approval of the Company’s executive compensation: For Against Abstentions Broker Non-Votes 1,506,477,171 11,181,420 309,881 74,228,233”

Hims & Hers Health, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“Proposal 2 : The ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: For Against Abstentions 1,591,246,881 516,386 433,438 As a routine proposal under applicable rules, no broker non-votes were recorded in connection with this proposal.”

Hims & Hers Health, Inc. shareholders approved Election of nine directors to serve as directors until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified at the 2026-06-11 meeting.

“Proposal 1 : The election of nine directors to serve as directors until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified: Name For Withheld Broker Non-Votes Andrew Dudum 1,504,939,830 13,028,642 74,228,233 Kofi Amoo-Gottfried 1,517,440,666 527,806 74,228,233 Deborah Autor 1,516,370,269 1,598,203 74,228,233 Delos Cosgrove, M.D. 1,516,949,085 1,019,387 74,228,233 Anja Manuel 1,516,973,593 994,879 74,228,233 Christopher Payne 1,508,808,309 9,160,163 74,228,233 Andrea Perez 1,516,871,986 1,096,486 74,228,233 Kare Schultz 1,516,971,244 997,228 74,228,233 David Wells 1,501,758,393 16,210,079 74,228,233”

Virgin Galactic Holdings, Inc shareholders approved Advisory vote to approve the frequency of future advisory votes on the compensation of the Company’s named executive officers at the 2026-06-11 meeting.

“Proposal 5 – An advisory (non-binding) vote to approve the frequency of future advisory votes on the compensation of the Company’s named executive officers. ONE YEAR TWO YEARS THREE YEARS ABSTAINED BROKER NON-VOTES 10,161,566 382,155 461,090 228,478 33,317,789”

Virgin Galactic Holdings, Inc shareholders approved Approval of the Fourth Amended and Restated Virgin Galactic Holdings, Inc. 2019 Incentive Award Plan at the 2026-06-11 meeting.

“Proposal 4 – Approval of the Fourth Amended and Restated Virgin Galactic Holdings, Inc. 2019 Incentive Award Plan. FOR AGAINST ABSTAINED BROKER NON-VOTES 9,270,078 1,757,066 206,149 33,317,785”

Virgin Galactic Holdings, Inc shareholders approved Advisory approval of the compensation of the Company’s named executive officers at the 2026-06-11 meeting.

“Proposal 3 – Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers. FOR AGAINST ABSTAINED BROKER NON-VOTES 7,369,092 3,620,695 243,503 33,317,788”

Virgin Galactic Holdings, Inc shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2026 at the 2026-06-11 meeting.

“Proposal 2 – Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2026. FOR AGAINST ABSTAINED BROKER NON-VOTES 43,076,193 1,268,348 206,537 -”

Virgin Galactic Holdings, Inc shareholders approved Election of Directors at the 2026-06-11 meeting.

“Proposal 1 – Election of directors to hold office until the Company’s annual meeting of stockholders to be held in 2027 and until their respective successors have been duly elected and qualified, or until their earlier death, resignation or removal. NAME OF DIRECTOR FOR WITHHELD BROKER NON-VOTES Raymond Mabus, Jr. 10,547,129 686,169 33,317,780 Michael Colglazier 10,435,294 798,004 33,317,780 Henio Arcangeli, Jr. 9,752,087 1,481,211 33,317,780 Allison Belzberg 10,469,742 763,557 33,317,779 Tina Jonas 10,529,459 703,840 33,317,779 Craig Kreeger 9,794,137 1,439,161 33,317,780 Wanda Sigur 10,553,397 679,902 33,317,779 Diana Strandberg 8,968,272 2,265,027 33,317,779 W. Gilbert West 10,391,933 841,365 33,317,780”